Boron-containing small molecules as antiprotozoal agents

US10301329B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10301329-B2
Application numberUS-201615227112-A
CountryUS
Kind codeB2
Filing dateAug 3, 2016
Priority dateAug 14, 2009
Publication dateMay 28, 2019
Grant dateMay 28, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of killing and/or preventing the growth of Trypanosoma brucei brucei, comprising: contacting the Trypanosoma brucei brucei with an effective amount of a compound having a structure according to the following formula: or a pharmaceutically acceptable salt thereof, thereby killing and/or preventing the growth of the Trypanosoma brucei brucei.

Assignees

Inventors

Classifications

  • Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis · CPC title

  • Boron compounds · CPC title

  • C07F5/025Primary

    Boronic and borinic acid compounds · CPC title

  • containing boron · CPC title

  • Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10301329B2 cover?
This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
Who is the assignee on this patent?
Anacor Pharmaceuticals Inc
What technology area does this patent fall under?
Primary CPC classification C07F5/025. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).